About Technology Issues FAQ

Links

Official Page

Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer

Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.